Evidence map›Paper›PMID 39915028›Full record

ArticleBMJ open2025

Global, regional and national burden of asthma attributable to NO

Jingli Li, Chunyi Zhang, E Qin, Jian Sun, Lingjing Liu, Guimei Pu

Abstract read
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jingli LiShaoxing People's Hospital, Shaoxing, Zhejiang, China.ORCID http://orcid.org/0000-0001-6392-6685
Chunyi ZhangShaoxing People's Hospital, Shaoxing, Zhejiang, China.
E QinShaoxing People's Hospital, Shaoxing, Zhejiang, China.
Jian SunShaoxing People's Hospital, Shaoxing, Zhejiang, China.
Lingjing LiuWenzhou Medical University First Affiliated Hospital, Wenzhou, Zhejiang, China.
Guimei PuShaoxing People's Hospital, Shaoxing, Zhejiang, China iampuguimei@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aims to systematically assess the global, regional, and national burden of asthma attributable to nitrogen dioxide (NO₂) pollution. DESIGN AND

settingAnalysis of population-level data from 1990 to 2021 obtained from the Global Burden of Disease Study 2021, covering 204 countries and territories.

participantsParticipants included patients with asthma attributable to NO₂ pollution. MAIN OUTCOMES AND MEASURES: Asthma-related disability-adjusted life-years (DALYs) and age-standardised DALY rates (ASDR) attributable to NO₂ pollution across 204 countries and territories. The estimated annual percentage change (EAPC) was used to assess temporal trends to identify regions with increasing or decreasing asthma burdens.

resultsIn 2021, NO₂ pollution contributed to approximately 176.73 thousand DALYs globally, with an ASDR of 2.48 per 100 000 population (95% uncertainty interval (UI) -2.26 to 10.30). The global ASDR declined significantly from 1990 to 2021, with an EAPC of -1.93% (95% CI -2.14% to -1.72%). High-income North America had the highest ASDR (10.74 per 100 000; 95% UI 10.12 to 46.56), while Australasia experienced the most significant reduction in ASDR over the study period (EAPC -3.92%; 95% CI -4.46% to -3.37%). In contrast, Oceania and Southeast Asia showed increasing trends in asthma burden, with EAPCs of 2.33% (95% CI 1.57% to 3.10%) and 1.14% (95% CI 0.81% to 1.47%), respectively. The 5-9 age group carried the highest asthma burden, reflecting the vulnerability of younger children to NO₂ exposure. A positive correlation between ASDR and sociodemographic index (SDI) was observed (R=0.637, p<0.001), indicating a greater asthma burden in higher SDI regions.

conclusionThe findings highlight significant regional and demographic disparities in asthma burden attributable to NO₂ pollution. Tailored public health strategies are needed to address the rising burden in vulnerable regions. Future research should focus on identifying effective interventions to reduce NO₂ exposure and improve asthma outcomes, especially in rapidly developing areas.

Indexed as

Air PollutantsAir PollutionAsthmaEnvironmental ExposureNitrogen DioxideAdolescentAdultAgedChildChild, PreschoolCost of IllnessDisability-Adjusted Life YearsFemaleGlobal Burden of DiseaseGlobal HealthHumansAir PollutantsNitrogen DioxideAsthmaHealth policyPUBLIC HEALTH

Identifiers

PMID39915028
PMCPMC11800289

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.